Patents Assigned to Xcovery Holding, LLC
  • PI3K isoform selective inhibitors
    Patent number: 8513221
    Abstract: 2-Morpholin-4-yl-9H-purine and 5-Morpholin-4-yl-3H-[1,2,3]triazolo[4,5-d]pyrimidine derivatives, especially those substituted by 6-heteroaryl, are unexpected PI3 kinase isoform selective inhibitors with good drug properties and are useful in treating disorders related to abnormal PI3K activities such as cancer, immune disorders, cardiovascular disease, viral infection, inflammation, metabolism/endocrine disorders and neurological disorders.
    Type: Grant
    Filed: July 7, 2009
    Date of Patent: August 20, 2013
    Assignee: Xcovery Holding, LLC
    Inventors: Congxin Liang, Zhigang Li